Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Caffeine, CYP1A2 and ADORA2A Genotypes on Cycling Endurance Performance.

NCT06547307 is registered in ClinicalTrials.gov with Masaryk University as lead sponsor.

NCT NCT06547307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06547307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Caffeine, CYP1A2 and ADORA2A Genotypes on Cycling Endurance Performance.
Lead sponsor
Masaryk University
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2024
Completion date
March 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy